Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances Podcast Por  arte de portada

Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Escúchala gratis

Ver detalles del espectáculo

Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Sara M Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data with antibody-drug conjugates in the management of breast cancer.

CME information and select publications here.

Todavía no hay opiniones